by Valet | Mar 30, 2021 | Clinical Trial, FDA Approved Clinical Trial, Press Release
Personalized Stem Cells, Inc (PSC), a clinical stage biopharma cell therapy company, announces the results of its single knee osteoarthritis phase 1/2a clinical trial. The final study report has been submitted to the FDA for review and in support of a full-scale...
by Ashley | May 26, 2020 | Press Release
Personalized Stem Cells, Inc (PSC), a human adipose-derived stem cell company, has continued enrollment for participation in an FDA approved clinical trial for stem cell treatment of knee osteoarthritis. Though the trial never stopped, in-person visits were halted,...
by Valet | Apr 14, 2020 | Blog, COVID-19, Stem Cell Therapy
Recently, Personalized Stem Cells (PSC) was asked by the White House Task Force to apply to the FDA for expedited review of their application for using stem cells to treat patients with COVID-19. Stem cell therapy is a distinct approach that treats lung inflammation...
by Ashley | Nov 25, 2019 | Blog, FDA Approved Clinical Trial, Knee Osteoarthritis, Stem Cell Therapy
As you may know, Personalized Stem Cells (PSC) has begun providing autologous adipose-derived stem cell therapy services to a select few physicians in the United States for the treatment of osteoarthritis in the knee through a clinical trial. This initial clinical...
